FDA panel raises concerns over memory lapses seen with experimental weight loss drug
FDA panel worries about psych effects of diet pill FDA panel says AstraZeneca’s cholesterol pill Crestor can curb heart problems more images FDA panel rejects Zimmer spine repair device on questions of safety and effectiveness
FDA panel rejects Zimmer spine implant GAITHERSBURG, Md. — Federal health advisers on Wednesday rejected an implant from Zimmer Holdings saying it’s unclear how effective or safe the device would be for treating a painful spinal condition. FDA panel questions long-term safety and effectiveness of Zimmer spine repair device
FDA panel has questions about Zimmer spine implant FDA advisers unanimously back GlaxoSmithKline drug for kidney cancer, despite liver risksFDA panel unanimously backs Glaxo cancer drug GAITHERSBURG, Md. — Federal health advisers said Monday an experimental kidney cancer drug from GlaxoSmithKline PLC can benefit patients by slowing the disease, despite some risk of liver damage. FDA panel narrowly backs Schering-Plough’s PegIntron as a skin cancer medicationFDA panel backs Schering-Plough cancer drug GAITHERSBURG, Md. — Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer. |
Latest TweetsGaithersburg
Latest Friend FeedsGaithersburg
|
